Kershaw, Michael H.
The University of Melbourne · Peter MacCallum Cancer Centre
2 papers on CoChatORCID 0000-0002-2697-487X
Most cited papers
- Verified
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
Dushyanthen, S., Teo, Z. L., Caramia, F., Savas, P., Mintoff, C. P., Virassamy, B., Henderson, M. A., Luen, S. J., Mansour, M., Kershaw, M. H., et al. (2017) · Nature Communications
Cancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways
Cited by 124
- Verified
Dual PD-1 and CTLA-4 checkpoint blockade promotes antitumor immune responses through CD4(+)Foxp3(-) cell-mediated modulation of CD103(+) dendritic cells
Beavis, P. A., Henderson, M. A., Giuffrida, L., Davenport, A. J., Petley, E. V., House, I. G., Lai, J., Sek, K., Milenkovski, N., John, L. B., et al. (2018) · Cancer Immunology Research
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 68
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free